Clover Health Investments, Corp.

Clover Health Investments, Corp. Q1 2026 Earnings Recap

CLOV Q1 2026 May 9, 2026

Get alerts when CLOV reports next quarter

Set up alerts — free

Shares jumped 16.4% post-earnings, reflecting investor approval of Clover Health's 51% year-over-year membership growth and return to GAAP net income profitability, underscoring confidence in the company’s tech-driven care model and scalable Medicare Advantage platform.

Earnings Per Share Beat
$0.07 vs $0.07 est.
+0.0% surprise
Revenue Beat
749189000 vs 714893900 est.
+4.8% surprise

Market Reaction

1-Day +2.5%

See CLOV alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Membership increased 51% year-over-year, driven primarily by growth in core New Jersey PPO markets.
  • GAAP net income returned to positive $27 million this quarter, signaling improved financial discipline and operating leverage.
  • Over one-third of members received Clover Assistant-powered care, supporting the company’s targeted clinical engagement strategy.
  • Management moderated in-year growth to prioritize clinical integration, aiming for sustainable cohort economics versus short-term expansion.
  • Positioned well for 2027 with CMS maintaining stable risk adjustment and favorable regulatory changes supporting encounter-based documentation.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit CLOV on AllInvestView.

Get the Full Picture on CLOV

Track Clover Health Investments, Corp. in your portfolio with real-time analytics, dividend tracking, and more.

View CLOV Analysis